Kailera Therapeutics (KLRA) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Kailera Therapeutics reported total assets of $692.29M and total liabilities of $56.39M. Shareholders' equity was $635.91M, up 270.7% from $171.53M a year earlier. Total debt stood at $10.75M against $546.06M in cash and short-term investments, a net cash position of $535.30M. That puts debt-to-equity at 0.02.

Kailera Therapeutics Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Kailera Therapeutics, Inc. (KLRA) - Annual data in millions USD
Breakdown	FY 2025	FY 2024
Period ending	Dec 2025	Dec 2024
Current Assets
Cash and Cash Equivalents	160.27	175.18
Short-Term Investments	385.79	-
Cash & Short-Term Investments	546.06	175.18
Accounts Receivable	2.73	-
Inventory	0.00	-
Other Current Assets	11.48	2.09
Total Current Assets	557.54	177.61
Non-Current Assets
Property, Plant & Equipment (Net)	12.42	0.68
Long-Term Investments	106.67	-
Other Non-Current Assets	15.67	0.15
Total Non-Current Assets	134.76	0.83
Total Assets	692.29	178.45
Current Liabilities
Accounts Payable	7.53	2.01
Short-Term Debt	1.04	-
Accrued Liabilities	37.84	2.23
Other Current Liabilities	0.92	2.16
Total Current Liabilities	46.41	6.91
Non-Current Liabilities
Long-Term Debt	9.71	-
Other Non-Current Liabilities	0.27	-
Total Non-Current Liabilities	9.98	390.31
Total Liabilities	56.39	6.91
Stockholders' Equity
Retained Earnings	-368.67	-219.71
Accumulated Other Comprehensive Income	0.23	-
Additional Paid-in Capital	11.98	0.94
Shares Outstanding	117.95	117.95
Total Stockholders' Equity	635.91	171.53
Total Liabilities & Equity	692.29	178.45

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Kailera Therapeutics Balance Sheet

How much debt does Kailera Therapeutics have?

Kailera Therapeutics had total debt of $10.75M as of Dec 31, 2025, against $546.06M in cash and short-term investments. Its debt-to-equity ratio was 0.02.

What are Kailera Therapeutics's total assets?

Kailera Therapeutics reported total assets of $692.29M as of Dec 31, 2025, up 288.0% from $178.44M a year earlier. Total liabilities were $56.39M.

What is Kailera Therapeutics's shareholders' equity?

Kailera Therapeutics's shareholders' equity was $635.91M as of Dec 31, 2025, or about $5.39 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition